Activation	B:C0014429
of	O
general	O
control	I:C2354171
nonderepressible	I:C2354171
2	I:C2354171
kinase	I:C2354171
protects	O
human	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
from	O
harmful	O
high	O
-	I:C0860803
glucose	I:C0860803
-	O
induced	O
molecular	O
pathways	I:C1704259
.	O

Activation	O
of	O
general	B:C2354171
control	I:C2354171
nonderepressible	I:C2354171
2	I:C2354171
kinase	I:C2354171
protects	O
human	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
from	O
harmful	O
high	O
-	I:C0860803
glucose	I:C0860803
-	O
induced	O
molecular	O
pathways	I:C1704259
.	O

Activation	O
of	O
general	O
control	I:C2354171
nonderepressible	I:C2354171
2	I:C2354171
kinase	I:C2354171
protects	O
human	B:C0086418
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
from	O
harmful	O
high	O
-	I:C0860803
glucose	I:C0860803
-	O
induced	O
molecular	O
pathways	I:C1704259
.	O

Activation	O
of	O
general	O
control	I:C2354171
nonderepressible	I:C2354171
2	I:C2354171
kinase	I:C2354171
protects	O
human	O
glomerular	B:C1182791
endothelial	I:C1182791
cells	I:C1182791
from	O
harmful	O
high	O
-	I:C0860803
glucose	I:C0860803
-	O
induced	O
molecular	O
pathways	I:C1704259
.	O

Activation	O
of	O
general	O
control	I:C2354171
nonderepressible	I:C2354171
2	I:C2354171
kinase	I:C2354171
protects	O
human	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
from	O
harmful	O
high	B:C0860803
-	I:C0860803
glucose	I:C0860803
-	O
induced	O
molecular	O
pathways	I:C1704259
.	O

Activation	O
of	O
general	O
control	I:C2354171
nonderepressible	I:C2354171
2	I:C2354171
kinase	I:C2354171
protects	O
human	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
from	O
harmful	O
high	O
-	I:C0860803
glucose	I:C0860803
-	O
induced	O
molecular	B:C1704259
pathways	I:C1704259
.	O

Considering	O
the	O
referred	O
beneficial	O
effects	O
of	O
protein	B:C0033684
restriction	O
on	O
diabetic	O
nephropathy	I:C0011881
(	O
diabetic	O
nephropathy	I:C0011881
)	O
and	O
the	O
role	O
of	O
renal	O
endothelium	O
in	O
its	O
pathogenesis	O
,	O
we	O
evaluated	O
the	O
effect	O
of	O
general	O
control	I:C2354171
nonderepressible	I:C2354171
2	I:C2354171
(	I:C2354171
GCN2	I:C2354171
)	I:C2354171
kinase	I:C2354171
activation	O
,	O
a	O
sensor	O
of	O
amino	O
acid	I:C0002520
deprivation	O
,	O
on	O
known	O
detrimental	O
molecular	O
pathways	I:C1704259
in	O
primary	O
human	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
(	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
)	O
.	O

Considering	O
the	O
referred	O
beneficial	O
effects	O
of	O
protein	O
restriction	O
on	O
diabetic	B:C0011881
nephropathy	I:C0011881
(	O
diabetic	O
nephropathy	I:C0011881
)	O
and	O
the	O
role	O
of	O
renal	O
endothelium	O
in	O
its	O
pathogenesis	O
,	O
we	O
evaluated	O
the	O
effect	O
of	O
general	O
control	I:C2354171
nonderepressible	I:C2354171
2	I:C2354171
(	I:C2354171
GCN2	I:C2354171
)	I:C2354171
kinase	I:C2354171
activation	O
,	O
a	O
sensor	O
of	O
amino	O
acid	I:C0002520
deprivation	O
,	O
on	O
known	O
detrimental	O
molecular	O
pathways	I:C1704259
in	O
primary	O
human	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
(	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
)	O
.	O

Considering	O
the	O
referred	O
beneficial	O
effects	O
of	O
protein	O
restriction	O
on	O
diabetic	O
nephropathy	I:C0011881
(	O
diabetic	B:C0011881
nephropathy	I:C0011881
)	O
and	O
the	O
role	O
of	O
renal	O
endothelium	O
in	O
its	O
pathogenesis	O
,	O
we	O
evaluated	O
the	O
effect	O
of	O
general	O
control	I:C2354171
nonderepressible	I:C2354171
2	I:C2354171
(	I:C2354171
GCN2	I:C2354171
)	I:C2354171
kinase	I:C2354171
activation	O
,	O
a	O
sensor	O
of	O
amino	O
acid	I:C0002520
deprivation	O
,	O
on	O
known	O
detrimental	O
molecular	O
pathways	I:C1704259
in	O
primary	O
human	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
(	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
)	O
.	O

Considering	O
the	O
referred	O
beneficial	O
effects	O
of	O
protein	O
restriction	O
on	O
diabetic	O
nephropathy	I:C0011881
(	O
diabetic	O
nephropathy	I:C0011881
)	O
and	O
the	O
role	O
of	O
renal	B:C0022646
endothelium	O
in	O
its	O
pathogenesis	O
,	O
we	O
evaluated	O
the	O
effect	O
of	O
general	O
control	I:C2354171
nonderepressible	I:C2354171
2	I:C2354171
(	I:C2354171
GCN2	I:C2354171
)	I:C2354171
kinase	I:C2354171
activation	O
,	O
a	O
sensor	O
of	O
amino	O
acid	I:C0002520
deprivation	O
,	O
on	O
known	O
detrimental	O
molecular	O
pathways	I:C1704259
in	O
primary	O
human	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
(	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
)	O
.	O

Considering	O
the	O
referred	O
beneficial	O
effects	O
of	O
protein	O
restriction	O
on	O
diabetic	O
nephropathy	I:C0011881
(	O
diabetic	O
nephropathy	I:C0011881
)	O
and	O
the	O
role	O
of	O
renal	O
endothelium	B:C0014257
in	O
its	O
pathogenesis	O
,	O
we	O
evaluated	O
the	O
effect	O
of	O
general	O
control	I:C2354171
nonderepressible	I:C2354171
2	I:C2354171
(	I:C2354171
GCN2	I:C2354171
)	I:C2354171
kinase	I:C2354171
activation	O
,	O
a	O
sensor	O
of	O
amino	O
acid	I:C0002520
deprivation	O
,	O
on	O
known	O
detrimental	O
molecular	O
pathways	I:C1704259
in	O
primary	O
human	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
(	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
)	O
.	O

Considering	O
the	O
referred	O
beneficial	O
effects	O
of	O
protein	O
restriction	O
on	O
diabetic	O
nephropathy	I:C0011881
(	O
diabetic	O
nephropathy	I:C0011881
)	O
and	O
the	O
role	O
of	O
renal	O
endothelium	O
in	O
its	O
pathogenesis	B:C0699748
,	O
we	O
evaluated	O
the	O
effect	O
of	O
general	O
control	I:C2354171
nonderepressible	I:C2354171
2	I:C2354171
(	I:C2354171
GCN2	I:C2354171
)	I:C2354171
kinase	I:C2354171
activation	O
,	O
a	O
sensor	O
of	O
amino	O
acid	I:C0002520
deprivation	O
,	O
on	O
known	O
detrimental	O
molecular	O
pathways	I:C1704259
in	O
primary	O
human	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
(	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
)	O
.	O

Considering	O
the	O
referred	O
beneficial	O
effects	O
of	O
protein	O
restriction	O
on	O
diabetic	O
nephropathy	I:C0011881
(	O
diabetic	O
nephropathy	I:C0011881
)	O
and	O
the	O
role	O
of	O
renal	O
endothelium	O
in	O
its	O
pathogenesis	O
,	O
we	O
evaluated	B:C0220825
the	O
effect	O
of	O
general	O
control	I:C2354171
nonderepressible	I:C2354171
2	I:C2354171
(	I:C2354171
GCN2	I:C2354171
)	I:C2354171
kinase	I:C2354171
activation	O
,	O
a	O
sensor	O
of	O
amino	O
acid	I:C0002520
deprivation	O
,	O
on	O
known	O
detrimental	O
molecular	O
pathways	I:C1704259
in	O
primary	O
human	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
(	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
)	O
.	O

Considering	O
the	O
referred	O
beneficial	O
effects	O
of	O
protein	O
restriction	O
on	O
diabetic	O
nephropathy	I:C0011881
(	O
diabetic	O
nephropathy	I:C0011881
)	O
and	O
the	O
role	O
of	O
renal	O
endothelium	O
in	O
its	O
pathogenesis	O
,	O
we	O
evaluated	O
the	O
effect	O
of	O
general	B:C2354171
control	I:C2354171
nonderepressible	I:C2354171
2	I:C2354171
(	I:C2354171
GCN2	I:C2354171
)	I:C2354171
kinase	I:C2354171
activation	O
,	O
a	O
sensor	O
of	O
amino	O
acid	I:C0002520
deprivation	O
,	O
on	O
known	O
detrimental	O
molecular	O
pathways	I:C1704259
in	O
primary	O
human	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
(	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
)	O
.	O

Considering	O
the	O
referred	O
beneficial	O
effects	O
of	O
protein	O
restriction	O
on	O
diabetic	O
nephropathy	I:C0011881
(	O
diabetic	O
nephropathy	I:C0011881
)	O
and	O
the	O
role	O
of	O
renal	O
endothelium	O
in	O
its	O
pathogenesis	O
,	O
we	O
evaluated	O
the	O
effect	O
of	O
general	O
control	I:C2354171
nonderepressible	I:C2354171
2	I:C2354171
(	I:C2354171
GCN2	I:C2354171
)	I:C2354171
kinase	I:C2354171
activation	B:C0014429
,	O
a	O
sensor	O
of	O
amino	O
acid	I:C0002520
deprivation	O
,	O
on	O
known	O
detrimental	O
molecular	O
pathways	I:C1704259
in	O
primary	O
human	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
(	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
)	O
.	O

Considering	O
the	O
referred	O
beneficial	O
effects	O
of	O
protein	O
restriction	O
on	O
diabetic	O
nephropathy	I:C0011881
(	O
diabetic	O
nephropathy	I:C0011881
)	O
and	O
the	O
role	O
of	O
renal	O
endothelium	O
in	O
its	O
pathogenesis	O
,	O
we	O
evaluated	O
the	O
effect	O
of	O
general	O
control	I:C2354171
nonderepressible	I:C2354171
2	I:C2354171
(	I:C2354171
GCN2	I:C2354171
)	I:C2354171
kinase	I:C2354171
activation	O
,	O
a	O
sensor	O
of	O
amino	B:C0002520
acid	I:C0002520
deprivation	O
,	O
on	O
known	O
detrimental	O
molecular	O
pathways	I:C1704259
in	O
primary	O
human	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
(	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
)	O
.	O

Considering	O
the	O
referred	O
beneficial	O
effects	O
of	O
protein	O
restriction	O
on	O
diabetic	O
nephropathy	I:C0011881
(	O
diabetic	O
nephropathy	I:C0011881
)	O
and	O
the	O
role	O
of	O
renal	O
endothelium	O
in	O
its	O
pathogenesis	O
,	O
we	O
evaluated	O
the	O
effect	O
of	O
general	O
control	I:C2354171
nonderepressible	I:C2354171
2	I:C2354171
(	I:C2354171
GCN2	I:C2354171
)	I:C2354171
kinase	I:C2354171
activation	O
,	O
a	O
sensor	O
of	O
amino	O
acid	I:C0002520
deprivation	O
,	O
on	O
known	O
detrimental	O
molecular	B:C1704259
pathways	I:C1704259
in	O
primary	O
human	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
(	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
)	O
.	O

Considering	O
the	O
referred	O
beneficial	O
effects	O
of	O
protein	O
restriction	O
on	O
diabetic	O
nephropathy	I:C0011881
(	O
diabetic	O
nephropathy	I:C0011881
)	O
and	O
the	O
role	O
of	O
renal	O
endothelium	O
in	O
its	O
pathogenesis	O
,	O
we	O
evaluated	O
the	O
effect	O
of	O
general	O
control	I:C2354171
nonderepressible	I:C2354171
2	I:C2354171
(	I:C2354171
GCN2	I:C2354171
)	I:C2354171
kinase	I:C2354171
activation	O
,	O
a	O
sensor	O
of	O
amino	O
acid	I:C0002520
deprivation	O
,	O
on	O
known	O
detrimental	O
molecular	O
pathways	I:C1704259
in	O
primary	O
human	B:C0086418
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
(	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
)	O
.	O

Considering	O
the	O
referred	O
beneficial	O
effects	O
of	O
protein	O
restriction	O
on	O
diabetic	O
nephropathy	I:C0011881
(	O
diabetic	O
nephropathy	I:C0011881
)	O
and	O
the	O
role	O
of	O
renal	O
endothelium	O
in	O
its	O
pathogenesis	O
,	O
we	O
evaluated	O
the	O
effect	O
of	O
general	O
control	I:C2354171
nonderepressible	I:C2354171
2	I:C2354171
(	I:C2354171
GCN2	I:C2354171
)	I:C2354171
kinase	I:C2354171
activation	O
,	O
a	O
sensor	O
of	O
amino	O
acid	I:C0002520
deprivation	O
,	O
on	O
known	O
detrimental	O
molecular	O
pathways	I:C1704259
in	O
primary	O
human	O
glomerular	B:C1182791
endothelial	I:C1182791
cells	I:C1182791
(	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
)	O
.	O

Considering	O
the	O
referred	O
beneficial	O
effects	O
of	O
protein	O
restriction	O
on	O
diabetic	O
nephropathy	I:C0011881
(	O
diabetic	O
nephropathy	I:C0011881
)	O
and	O
the	O
role	O
of	O
renal	O
endothelium	O
in	O
its	O
pathogenesis	O
,	O
we	O
evaluated	O
the	O
effect	O
of	O
general	O
control	I:C2354171
nonderepressible	I:C2354171
2	I:C2354171
(	I:C2354171
GCN2	I:C2354171
)	I:C2354171
kinase	I:C2354171
activation	O
,	O
a	O
sensor	O
of	O
amino	O
acid	I:C0002520
deprivation	O
,	O
on	O
known	O
detrimental	O
molecular	O
pathways	I:C1704259
in	O
primary	O
human	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
(	O
glomerular	B:C1182791
endothelial	I:C1182791
cells	I:C1182791
)	O
.	O

glomerular	B:C1182791
endothelial	I:C1182791
cells	I:C1182791
were	O
cultured	O
under	O
normal	O
or	O
high	O
-	I:C0020456
glucose	I:C0020456
conditions	I:C0020456
in	O
the	O
presence	O
or	O
not	O
of	O
the	O
GCN2	O
kinase	I:C2354171
activator	O
,	O
tryptophanol	O
.	O

glomerular	O
endothelial	I:C1182791
cells	I:C1182791
were	O
cultured	B:C0430400
under	O
normal	O
or	O
high	O
-	I:C0020456
glucose	I:C0020456
conditions	I:C0020456
in	O
the	O
presence	O
or	O
not	O
of	O
the	O
GCN2	O
kinase	I:C2354171
activator	O
,	O
tryptophanol	O
.	O

glomerular	O
endothelial	I:C1182791
cells	I:C1182791
were	O
cultured	O
under	O
normal	O
or	O
high	B:C0020456
-	I:C0020456
glucose	I:C0020456
conditions	I:C0020456
in	O
the	O
presence	O
or	O
not	O
of	O
the	O
GCN2	O
kinase	I:C2354171
activator	O
,	O
tryptophanol	O
.	O

glomerular	O
endothelial	I:C1182791
cells	I:C1182791
were	O
cultured	O
under	O
normal	O
or	O
high	O
-	I:C0020456
glucose	I:C0020456
conditions	I:C0020456
in	O
the	O
presence	O
or	O
not	O
of	O
the	O
GCN2	B:C2354171
kinase	I:C2354171
activator	O
,	O
tryptophanol	O
.	O

glomerular	O
endothelial	I:C1182791
cells	I:C1182791
were	O
cultured	O
under	O
normal	O
or	O
high	O
-	I:C0020456
glucose	I:C0020456
conditions	I:C0020456
in	O
the	O
presence	O
or	O
not	O
of	O
the	O
GCN2	O
kinase	I:C2354171
activator	B:C2247123
,	O
tryptophanol	O
.	O

glomerular	O
endothelial	I:C1182791
cells	I:C1182791
were	O
cultured	O
under	O
normal	O
or	O
high	O
-	I:C0020456
glucose	I:C0020456
conditions	I:C0020456
in	O
the	O
presence	O
or	O
not	O
of	O
the	O
GCN2	O
kinase	I:C2354171
activator	O
,	O
tryptophanol	B:C0526839
.	O

Glucose	B:C0168458
transporter	I:C0168458
1	I:C0168458
(	O
Glucose	O
transporter	I:C0168458
1	I:C0168458
)	O
expression	O
was	O
assessed	O
by	O
western	O
blotting	I:C0005863
and	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
using	O
a	O
fluorogenic	O
probe	I:C0016321
.	O

Glucose	O
transporter	I:C0168458
1	I:C0168458
(	O
Glucose	B:C0168458
transporter	I:C0168458
1	I:C0168458
)	O
expression	O
was	O
assessed	O
by	O
western	O
blotting	I:C0005863
and	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
using	O
a	O
fluorogenic	O
probe	I:C0016321
.	O

Glucose	O
transporter	I:C0168458
1	I:C0168458
(	O
Glucose	O
transporter	I:C0168458
1	I:C0168458
)	O
expression	B:C1171362
was	O
assessed	O
by	O
western	O
blotting	I:C0005863
and	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
using	O
a	O
fluorogenic	O
probe	I:C0016321
.	O

Glucose	O
transporter	I:C0168458
1	I:C0168458
(	O
Glucose	O
transporter	I:C0168458
1	I:C0168458
)	O
expression	O
was	O
assessed	O
by	O
western	B:C0005863
blotting	I:C0005863
and	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
using	O
a	O
fluorogenic	O
probe	I:C0016321
.	O

Glucose	O
transporter	I:C0168458
1	I:C0168458
(	O
Glucose	O
transporter	I:C0168458
1	I:C0168458
)	O
expression	O
was	O
assessed	O
by	O
western	O
blotting	I:C0005863
and	O
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
using	O
a	O
fluorogenic	O
probe	I:C0016321
.	O

Glucose	O
transporter	I:C0168458
1	I:C0168458
(	O
Glucose	O
transporter	I:C0168458
1	I:C0168458
)	O
expression	O
was	O
assessed	O
by	O
western	O
blotting	I:C0005863
and	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
)	O
using	O
a	O
fluorogenic	O
probe	I:C0016321
.	O

Glucose	O
transporter	I:C0168458
1	I:C0168458
(	O
Glucose	O
transporter	I:C0168458
1	I:C0168458
)	O
expression	O
was	O
assessed	O
by	O
western	O
blotting	I:C0005863
and	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
using	O
a	O
fluorogenic	B:C0016321
probe	I:C0016321
.	O

Activities	B:C0243102
of	O
glyceraldehyde	O
3	I:C3536868
-	I:C3536868
phosphate	I:C3536868
dehydrogenase	I:C3536868
(	O
glyceraldehyde	O
3	I:C3536868
-	I:C3536868
phosphate	I:C3536868
dehydrogenase	I:C3536868
)	O
and	O
protein	O
kinase	I:C0033634
C	I:C0033634
(	O
protein	O
kinase	I:C0033634
C	I:C0033634
)	O
were	O
assessed	O
by	O
commercial	O
activity	I:C0005507
assays	I:C0005507
,	O
sorbitol	O
colorimetrically	O
,	O
methylglyoxal	O
by	O
ELISA	O
and	O
O	O
-	I:C0671368
linked	I:C0671368
β-	I:C0671368
N	I:C0671368
-	I:C0671368
acetyl	I:C0671368
glucosamine	I:C0671368
(	I:C0671368
O	I:C0671368
-	I:C0671368
GlcNAc	I:C0671368
)	I:C0671368
-	I:C0671368
modified	I:C0671368
proteins	I:C0671368
by	O
western	O
blotting	I:C0005863
.	O

Activities	O
of	O
glyceraldehyde	B:C3536868
3	I:C3536868
-	I:C3536868
phosphate	I:C3536868
dehydrogenase	I:C3536868
(	O
glyceraldehyde	O
3	I:C3536868
-	I:C3536868
phosphate	I:C3536868
dehydrogenase	I:C3536868
)	O
and	O
protein	O
kinase	I:C0033634
C	I:C0033634
(	O
protein	O
kinase	I:C0033634
C	I:C0033634
)	O
were	O
assessed	O
by	O
commercial	O
activity	I:C0005507
assays	I:C0005507
,	O
sorbitol	O
colorimetrically	O
,	O
methylglyoxal	O
by	O
ELISA	O
and	O
O	O
-	I:C0671368
linked	I:C0671368
β-	I:C0671368
N	I:C0671368
-	I:C0671368
acetyl	I:C0671368
glucosamine	I:C0671368
(	I:C0671368
O	I:C0671368
-	I:C0671368
GlcNAc	I:C0671368
)	I:C0671368
-	I:C0671368
modified	I:C0671368
proteins	I:C0671368
by	O
western	O
blotting	I:C0005863
.	O

Activities	O
of	O
glyceraldehyde	O
3	I:C3536868
-	I:C3536868
phosphate	I:C3536868
dehydrogenase	I:C3536868
(	O
glyceraldehyde	B:C3536868
3	I:C3536868
-	I:C3536868
phosphate	I:C3536868
dehydrogenase	I:C3536868
)	O
and	O
protein	O
kinase	I:C0033634
C	I:C0033634
(	O
protein	O
kinase	I:C0033634
C	I:C0033634
)	O
were	O
assessed	O
by	O
commercial	O
activity	I:C0005507
assays	I:C0005507
,	O
sorbitol	O
colorimetrically	O
,	O
methylglyoxal	O
by	O
ELISA	O
and	O
O	O
-	I:C0671368
linked	I:C0671368
β-	I:C0671368
N	I:C0671368
-	I:C0671368
acetyl	I:C0671368
glucosamine	I:C0671368
(	I:C0671368
O	I:C0671368
-	I:C0671368
GlcNAc	I:C0671368
)	I:C0671368
-	I:C0671368
modified	I:C0671368
proteins	I:C0671368
by	O
western	O
blotting	I:C0005863
.	O

Activities	O
of	O
glyceraldehyde	O
3	I:C3536868
-	I:C3536868
phosphate	I:C3536868
dehydrogenase	I:C3536868
(	O
glyceraldehyde	O
3	I:C3536868
-	I:C3536868
phosphate	I:C3536868
dehydrogenase	I:C3536868
)	O
and	O
protein	B:C0033634
kinase	I:C0033634
C	I:C0033634
(	O
protein	O
kinase	I:C0033634
C	I:C0033634
)	O
were	O
assessed	O
by	O
commercial	O
activity	I:C0005507
assays	I:C0005507
,	O
sorbitol	O
colorimetrically	O
,	O
methylglyoxal	O
by	O
ELISA	O
and	O
O	O
-	I:C0671368
linked	I:C0671368
β-	I:C0671368
N	I:C0671368
-	I:C0671368
acetyl	I:C0671368
glucosamine	I:C0671368
(	I:C0671368
O	I:C0671368
-	I:C0671368
GlcNAc	I:C0671368
)	I:C0671368
-	I:C0671368
modified	I:C0671368
proteins	I:C0671368
by	O
western	O
blotting	I:C0005863
.	O

Activities	O
of	O
glyceraldehyde	O
3	I:C3536868
-	I:C3536868
phosphate	I:C3536868
dehydrogenase	I:C3536868
(	O
glyceraldehyde	O
3	I:C3536868
-	I:C3536868
phosphate	I:C3536868
dehydrogenase	I:C3536868
)	O
and	O
protein	O
kinase	I:C0033634
C	I:C0033634
(	O
protein	B:C0033634
kinase	I:C0033634
C	I:C0033634
)	O
were	O
assessed	O
by	O
commercial	O
activity	I:C0005507
assays	I:C0005507
,	O
sorbitol	O
colorimetrically	O
,	O
methylglyoxal	O
by	O
ELISA	O
and	O
O	O
-	I:C0671368
linked	I:C0671368
β-	I:C0671368
N	I:C0671368
-	I:C0671368
acetyl	I:C0671368
glucosamine	I:C0671368
(	I:C0671368
O	I:C0671368
-	I:C0671368
GlcNAc	I:C0671368
)	I:C0671368
-	I:C0671368
modified	I:C0671368
proteins	I:C0671368
by	O
western	O
blotting	I:C0005863
.	O

Activities	O
of	O
glyceraldehyde	O
3	I:C3536868
-	I:C3536868
phosphate	I:C3536868
dehydrogenase	I:C3536868
(	O
glyceraldehyde	O
3	I:C3536868
-	I:C3536868
phosphate	I:C3536868
dehydrogenase	I:C3536868
)	O
and	O
protein	O
kinase	I:C0033634
C	I:C0033634
(	O
protein	O
kinase	I:C0033634
C	I:C0033634
)	O
were	O
assessed	O
by	O
commercial	B:C0005507
activity	I:C0005507
assays	I:C0005507
,	O
sorbitol	O
colorimetrically	O
,	O
methylglyoxal	O
by	O
ELISA	O
and	O
O	O
-	I:C0671368
linked	I:C0671368
β-	I:C0671368
N	I:C0671368
-	I:C0671368
acetyl	I:C0671368
glucosamine	I:C0671368
(	I:C0671368
O	I:C0671368
-	I:C0671368
GlcNAc	I:C0671368
)	I:C0671368
-	I:C0671368
modified	I:C0671368
proteins	I:C0671368
by	O
western	O
blotting	I:C0005863
.	O

Activities	O
of	O
glyceraldehyde	O
3	I:C3536868
-	I:C3536868
phosphate	I:C3536868
dehydrogenase	I:C3536868
(	O
glyceraldehyde	O
3	I:C3536868
-	I:C3536868
phosphate	I:C3536868
dehydrogenase	I:C3536868
)	O
and	O
protein	O
kinase	I:C0033634
C	I:C0033634
(	O
protein	O
kinase	I:C0033634
C	I:C0033634
)	O
were	O
assessed	O
by	O
commercial	O
activity	I:C0005507
assays	I:C0005507
,	O
sorbitol	B:C0037688
colorimetrically	O
,	O
methylglyoxal	O
by	O
ELISA	O
and	O
O	O
-	I:C0671368
linked	I:C0671368
β-	I:C0671368
N	I:C0671368
-	I:C0671368
acetyl	I:C0671368
glucosamine	I:C0671368
(	I:C0671368
O	I:C0671368
-	I:C0671368
GlcNAc	I:C0671368
)	I:C0671368
-	I:C0671368
modified	I:C0671368
proteins	I:C0671368
by	O
western	O
blotting	I:C0005863
.	O

Activities	O
of	O
glyceraldehyde	O
3	I:C3536868
-	I:C3536868
phosphate	I:C3536868
dehydrogenase	I:C3536868
(	O
glyceraldehyde	O
3	I:C3536868
-	I:C3536868
phosphate	I:C3536868
dehydrogenase	I:C3536868
)	O
and	O
protein	O
kinase	I:C0033634
C	I:C0033634
(	O
protein	O
kinase	I:C0033634
C	I:C0033634
)	O
were	O
assessed	O
by	O
commercial	O
activity	I:C0005507
assays	I:C0005507
,	O
sorbitol	O
colorimetrically	B:C1531834
,	O
methylglyoxal	O
by	O
ELISA	O
and	O
O	O
-	I:C0671368
linked	I:C0671368
β-	I:C0671368
N	I:C0671368
-	I:C0671368
acetyl	I:C0671368
glucosamine	I:C0671368
(	I:C0671368
O	I:C0671368
-	I:C0671368
GlcNAc	I:C0671368
)	I:C0671368
-	I:C0671368
modified	I:C0671368
proteins	I:C0671368
by	O
western	O
blotting	I:C0005863
.	O

Activities	O
of	O
glyceraldehyde	O
3	I:C3536868
-	I:C3536868
phosphate	I:C3536868
dehydrogenase	I:C3536868
(	O
glyceraldehyde	O
3	I:C3536868
-	I:C3536868
phosphate	I:C3536868
dehydrogenase	I:C3536868
)	O
and	O
protein	O
kinase	I:C0033634
C	I:C0033634
(	O
protein	O
kinase	I:C0033634
C	I:C0033634
)	O
were	O
assessed	O
by	O
commercial	O
activity	I:C0005507
assays	I:C0005507
,	O
sorbitol	O
colorimetrically	O
,	O
methylglyoxal	B:C0034338
by	O
ELISA	O
and	O
O	O
-	I:C0671368
linked	I:C0671368
β-	I:C0671368
N	I:C0671368
-	I:C0671368
acetyl	I:C0671368
glucosamine	I:C0671368
(	I:C0671368
O	I:C0671368
-	I:C0671368
GlcNAc	I:C0671368
)	I:C0671368
-	I:C0671368
modified	I:C0671368
proteins	I:C0671368
by	O
western	O
blotting	I:C0005863
.	O

Activities	O
of	O
glyceraldehyde	O
3	I:C3536868
-	I:C3536868
phosphate	I:C3536868
dehydrogenase	I:C3536868
(	O
glyceraldehyde	O
3	I:C3536868
-	I:C3536868
phosphate	I:C3536868
dehydrogenase	I:C3536868
)	O
and	O
protein	O
kinase	I:C0033634
C	I:C0033634
(	O
protein	O
kinase	I:C0033634
C	I:C0033634
)	O
were	O
assessed	O
by	O
commercial	O
activity	I:C0005507
assays	I:C0005507
,	O
sorbitol	O
colorimetrically	O
,	O
methylglyoxal	O
by	O
ELISA	B:C0014441
and	O
O	O
-	I:C0671368
linked	I:C0671368
β-	I:C0671368
N	I:C0671368
-	I:C0671368
acetyl	I:C0671368
glucosamine	I:C0671368
(	I:C0671368
O	I:C0671368
-	I:C0671368
GlcNAc	I:C0671368
)	I:C0671368
-	I:C0671368
modified	I:C0671368
proteins	I:C0671368
by	O
western	O
blotting	I:C0005863
.	O

Activities	O
of	O
glyceraldehyde	O
3	I:C3536868
-	I:C3536868
phosphate	I:C3536868
dehydrogenase	I:C3536868
(	O
glyceraldehyde	O
3	I:C3536868
-	I:C3536868
phosphate	I:C3536868
dehydrogenase	I:C3536868
)	O
and	O
protein	O
kinase	I:C0033634
C	I:C0033634
(	O
protein	O
kinase	I:C0033634
C	I:C0033634
)	O
were	O
assessed	O
by	O
commercial	O
activity	I:C0005507
assays	I:C0005507
,	O
sorbitol	O
colorimetrically	O
,	O
methylglyoxal	O
by	O
ELISA	O
and	O
O	B:C0671368
-	I:C0671368
linked	I:C0671368
β-	I:C0671368
N	I:C0671368
-	I:C0671368
acetyl	I:C0671368
glucosamine	I:C0671368
(	I:C0671368
O	I:C0671368
-	I:C0671368
GlcNAc	I:C0671368
)	I:C0671368
-	I:C0671368
modified	I:C0671368
proteins	I:C0671368
by	O
western	O
blotting	I:C0005863
.	O

Activities	O
of	O
glyceraldehyde	O
3	I:C3536868
-	I:C3536868
phosphate	I:C3536868
dehydrogenase	I:C3536868
(	O
glyceraldehyde	O
3	I:C3536868
-	I:C3536868
phosphate	I:C3536868
dehydrogenase	I:C3536868
)	O
and	O
protein	O
kinase	I:C0033634
C	I:C0033634
(	O
protein	O
kinase	I:C0033634
C	I:C0033634
)	O
were	O
assessed	O
by	O
commercial	O
activity	I:C0005507
assays	I:C0005507
,	O
sorbitol	O
colorimetrically	O
,	O
methylglyoxal	O
by	O
ELISA	O
and	O
O	O
-	I:C0671368
linked	I:C0671368
β-	I:C0671368
N	I:C0671368
-	I:C0671368
acetyl	I:C0671368
glucosamine	I:C0671368
(	I:C0671368
O	I:C0671368
-	I:C0671368
GlcNAc	I:C0671368
)	I:C0671368
-	I:C0671368
modified	I:C0671368
proteins	I:C0671368
by	O
western	B:C0005863
blotting	I:C0005863
.	O

High	B:C0860803
glucose	I:C0860803
induced	O
Glucose	O
transporter	I:C0168458
1	I:C0168458
expression	O
,	O
increased	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
inhibited	O
glyceraldehyde	O
3	I:C3536868
-	I:C3536868
phosphate	I:C3536868
dehydrogenase	I:C3536868
.	O

High	O
glucose	I:C0860803
induced	O
Glucose	B:C0168458
transporter	I:C0168458
1	I:C0168458
expression	O
,	O
increased	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
inhibited	O
glyceraldehyde	O
3	I:C3536868
-	I:C3536868
phosphate	I:C3536868
dehydrogenase	I:C3536868
.	O

High	O
glucose	I:C0860803
induced	O
Glucose	O
transporter	I:C0168458
1	I:C0168458
expression	B:C1171362
,	O
increased	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
inhibited	O
glyceraldehyde	O
3	I:C3536868
-	I:C3536868
phosphate	I:C3536868
dehydrogenase	I:C3536868
.	O

High	O
glucose	I:C0860803
induced	O
Glucose	O
transporter	I:C0168458
1	I:C0168458
expression	O
,	O
increased	O
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
and	O
inhibited	O
glyceraldehyde	O
3	I:C3536868
-	I:C3536868
phosphate	I:C3536868
dehydrogenase	I:C3536868
.	O

High	O
glucose	I:C0860803
induced	O
Glucose	O
transporter	I:C0168458
1	I:C0168458
expression	O
,	O
increased	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
inhibited	O
glyceraldehyde	B:C3536868
3	I:C3536868
-	I:C3536868
phosphate	I:C3536868
dehydrogenase	I:C3536868
.	O

Also	O
it	O
increased	O
the	O
polyol	B:C0071629
pathway	O
product	O
sorbitol	O
,	O
protein	O
kinase	I:C0033634
C	I:C0033634
activity	O
,	O
the	O
level	O
of	O
the	O
O	O
-	I:C0671368
GlcNAc	I:C0671368
-	I:C0671368
modified	I:C0671368
proteins	I:C0671368
that	O
produced	O
by	O
the	O
hexosamine	O
pathway	O
and	O
the	O
advanced	O
glycation	I:C0162574
endproducts	I:C0162574
'	I:C0162574
precursor	O
methylglyoxal	O
.	O

Also	O
it	O
increased	O
the	O
polyol	O
pathway	B:C1704259
product	O
sorbitol	O
,	O
protein	O
kinase	I:C0033634
C	I:C0033634
activity	O
,	O
the	O
level	O
of	O
the	O
O	O
-	I:C0671368
GlcNAc	I:C0671368
-	I:C0671368
modified	I:C0671368
proteins	I:C0671368
that	O
produced	O
by	O
the	O
hexosamine	O
pathway	O
and	O
the	O
advanced	O
glycation	I:C0162574
endproducts	I:C0162574
'	I:C0162574
precursor	O
methylglyoxal	O
.	O

Also	O
it	O
increased	O
the	O
polyol	O
pathway	O
product	O
sorbitol	B:C0037688
,	O
protein	O
kinase	I:C0033634
C	I:C0033634
activity	O
,	O
the	O
level	O
of	O
the	O
O	O
-	I:C0671368
GlcNAc	I:C0671368
-	I:C0671368
modified	I:C0671368
proteins	I:C0671368
that	O
produced	O
by	O
the	O
hexosamine	O
pathway	O
and	O
the	O
advanced	O
glycation	I:C0162574
endproducts	I:C0162574
'	I:C0162574
precursor	O
methylglyoxal	O
.	O

Also	O
it	O
increased	O
the	O
polyol	O
pathway	O
product	O
sorbitol	O
,	O
protein	B:C0033634
kinase	I:C0033634
C	I:C0033634
activity	O
,	O
the	O
level	O
of	O
the	O
O	O
-	I:C0671368
GlcNAc	I:C0671368
-	I:C0671368
modified	I:C0671368
proteins	I:C0671368
that	O
produced	O
by	O
the	O
hexosamine	O
pathway	O
and	O
the	O
advanced	O
glycation	I:C0162574
endproducts	I:C0162574
'	I:C0162574
precursor	O
methylglyoxal	O
.	O

Also	O
it	O
increased	O
the	O
polyol	O
pathway	O
product	O
sorbitol	O
,	O
protein	O
kinase	I:C0033634
C	I:C0033634
activity	B:C0243102
,	O
the	O
level	O
of	O
the	O
O	O
-	I:C0671368
GlcNAc	I:C0671368
-	I:C0671368
modified	I:C0671368
proteins	I:C0671368
that	O
produced	O
by	O
the	O
hexosamine	O
pathway	O
and	O
the	O
advanced	O
glycation	I:C0162574
endproducts	I:C0162574
'	I:C0162574
precursor	O
methylglyoxal	O
.	O

Also	O
it	O
increased	O
the	O
polyol	O
pathway	O
product	O
sorbitol	O
,	O
protein	O
kinase	I:C0033634
C	I:C0033634
activity	O
,	O
the	O
level	O
of	O
the	O
O	B:C0671368
-	I:C0671368
GlcNAc	I:C0671368
-	I:C0671368
modified	I:C0671368
proteins	I:C0671368
that	O
produced	O
by	O
the	O
hexosamine	O
pathway	O
and	O
the	O
advanced	O
glycation	I:C0162574
endproducts	I:C0162574
'	I:C0162574
precursor	O
methylglyoxal	O
.	O

Also	O
it	O
increased	O
the	O
polyol	O
pathway	O
product	O
sorbitol	O
,	O
protein	O
kinase	I:C0033634
C	I:C0033634
activity	O
,	O
the	O
level	O
of	O
the	O
O	O
-	I:C0671368
GlcNAc	I:C0671368
-	I:C0671368
modified	I:C0671368
proteins	I:C0671368
that	O
produced	O
by	O
the	O
hexosamine	B:C0019477
pathway	O
and	O
the	O
advanced	O
glycation	I:C0162574
endproducts	I:C0162574
'	I:C0162574
precursor	O
methylglyoxal	O
.	O

Also	O
it	O
increased	O
the	O
polyol	O
pathway	O
product	O
sorbitol	O
,	O
protein	O
kinase	I:C0033634
C	I:C0033634
activity	O
,	O
the	O
level	O
of	O
the	O
O	O
-	I:C0671368
GlcNAc	I:C0671368
-	I:C0671368
modified	I:C0671368
proteins	I:C0671368
that	O
produced	O
by	O
the	O
hexosamine	O
pathway	B:C1704259
and	O
the	O
advanced	O
glycation	I:C0162574
endproducts	I:C0162574
'	I:C0162574
precursor	O
methylglyoxal	O
.	O

Also	O
it	O
increased	O
the	O
polyol	O
pathway	O
product	O
sorbitol	O
,	O
protein	O
kinase	I:C0033634
C	I:C0033634
activity	O
,	O
the	O
level	O
of	O
the	O
O	O
-	I:C0671368
GlcNAc	I:C0671368
-	I:C0671368
modified	I:C0671368
proteins	I:C0671368
that	O
produced	O
by	O
the	O
hexosamine	O
pathway	O
and	O
the	O
advanced	B:C0162574
glycation	I:C0162574
endproducts	I:C0162574
'	I:C0162574
precursor	O
methylglyoxal	O
.	O

Also	O
it	O
increased	O
the	O
polyol	O
pathway	O
product	O
sorbitol	O
,	O
protein	O
kinase	I:C0033634
C	I:C0033634
activity	O
,	O
the	O
level	O
of	O
the	O
O	O
-	I:C0671368
GlcNAc	I:C0671368
-	I:C0671368
modified	I:C0671368
proteins	I:C0671368
that	O
produced	O
by	O
the	O
hexosamine	O
pathway	O
and	O
the	O
advanced	O
glycation	I:C0162574
endproducts	I:C0162574
'	I:C0162574
precursor	O
methylglyoxal	B:C0034338
.	O

Co-treatment	O
of	O
glomerular	B:C1182791
endothelial	I:C1182791
cells	I:C1182791
with	O
tryptophanol	O
restored	O
the	O
above	O
high	O
-	I:C0860803
glucose	I:C0860803
-	O
induced	O
alterations	O
.	O

Co-treatment	O
of	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
with	O
tryptophanol	B:C0526839
restored	O
the	O
above	O
high	O
-	I:C0860803
glucose	I:C0860803
-	O
induced	O
alterations	O
.	O

Co-treatment	O
of	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
with	O
tryptophanol	O
restored	O
the	O
above	O
high	B:C0860803
-	I:C0860803
glucose	I:C0860803
-	O
induced	O
alterations	O
.	O

Activation	B:C0014429
of	O
GCN2	O
kinase	I:C2354171
protects	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
from	O
high	O
-	I:C0860803
glucose	I:C0860803
-	O
induced	O
harmful	O
molecular	O
pathways	I:C1704259
.	O

Activation	O
of	O
GCN2	B:C2354171
kinase	I:C2354171
protects	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
from	O
high	O
-	I:C0860803
glucose	I:C0860803
-	O
induced	O
harmful	O
molecular	O
pathways	I:C1704259
.	O

Activation	O
of	O
GCN2	O
kinase	I:C2354171
protects	O
glomerular	B:C1182791
endothelial	I:C1182791
cells	I:C1182791
from	O
high	O
-	I:C0860803
glucose	I:C0860803
-	O
induced	O
harmful	O
molecular	O
pathways	I:C1704259
.	O

Activation	O
of	O
GCN2	O
kinase	I:C2354171
protects	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
from	O
high	B:C0860803
-	I:C0860803
glucose	I:C0860803
-	O
induced	O
harmful	O
molecular	O
pathways	I:C1704259
.	O

Activation	O
of	O
GCN2	O
kinase	I:C2354171
protects	O
glomerular	O
endothelial	I:C1182791
cells	I:C1182791
from	O
high	O
-	I:C0860803
glucose	I:C0860803
-	O
induced	O
harmful	O
molecular	B:C1704259
pathways	I:C1704259
.	O

By	O
inhibiting	O
concurrently	O
many	O
pathways	B:C1704259
involved	O
in	O
diabetic	O
nephropathy	I:C0011881
pathogenesis	O
,	O
GCN2	O
kinase	I:C2354171
may	O
serve	O
as	O
a	O
pharmaceutical	O
target	O
for	O
the	O
treatment	O
of	O
diabetic	O
nephropathy	I:C0011881
.	O

By	O
inhibiting	O
concurrently	O
many	O
pathways	O
involved	O
in	O
diabetic	B:C0011881
nephropathy	I:C0011881
pathogenesis	O
,	O
GCN2	O
kinase	I:C2354171
may	O
serve	O
as	O
a	O
pharmaceutical	O
target	O
for	O
the	O
treatment	O
of	O
diabetic	O
nephropathy	I:C0011881
.	O

By	O
inhibiting	O
concurrently	O
many	O
pathways	O
involved	O
in	O
diabetic	O
nephropathy	I:C0011881
pathogenesis	B:C0699748
,	O
GCN2	O
kinase	I:C2354171
may	O
serve	O
as	O
a	O
pharmaceutical	O
target	O
for	O
the	O
treatment	O
of	O
diabetic	O
nephropathy	I:C0011881
.	O

By	O
inhibiting	O
concurrently	O
many	O
pathways	O
involved	O
in	O
diabetic	O
nephropathy	I:C0011881
pathogenesis	O
,	O
GCN2	B:C2354171
kinase	I:C2354171
may	O
serve	O
as	O
a	O
pharmaceutical	O
target	O
for	O
the	O
treatment	O
of	O
diabetic	O
nephropathy	I:C0011881
.	O

By	O
inhibiting	O
concurrently	O
many	O
pathways	O
involved	O
in	O
diabetic	O
nephropathy	I:C0011881
pathogenesis	O
,	O
GCN2	O
kinase	I:C2354171
may	O
serve	O
as	O
a	O
pharmaceutical	B:C0031336
target	O
for	O
the	O
treatment	O
of	O
diabetic	O
nephropathy	I:C0011881
.	O

By	O
inhibiting	O
concurrently	O
many	O
pathways	O
involved	O
in	O
diabetic	O
nephropathy	I:C0011881
pathogenesis	O
,	O
GCN2	O
kinase	I:C2354171
may	O
serve	O
as	O
a	O
pharmaceutical	O
target	O
for	O
the	O
treatment	B:C0087111
of	O
diabetic	O
nephropathy	I:C0011881
.	O

By	O
inhibiting	O
concurrently	O
many	O
pathways	O
involved	O
in	O
diabetic	O
nephropathy	I:C0011881
pathogenesis	O
,	O
GCN2	O
kinase	I:C2354171
may	O
serve	O
as	O
a	O
pharmaceutical	O
target	O
for	O
the	O
treatment	O
of	O
diabetic	B:C0011881
nephropathy	I:C0011881
.	O

